Abstract:(hereafter, abbreviated as "Center") was established in 1993 when the NIRS completed construction of the HIMAC. Since then it has been carrying out clinical, biological and physics research using heavy ions generated from the HIMAC. After accumulating clinical experiences of carbon ion radiotherapy in various types of malignant tumors, the Center was successful in obtaining approval from the Ministry of Health, Welfare and Labor for "Highly Advanced Medical Technology" in 2003. Thus carbon ion therapy has meanwhile achieved for itself a solid place in general practice. The HIMAC has been also served for >500 researchers as a multiuser utilization facility for medical, biological and physics research. In 2006, when the second Mid-Term of the NIRS was initiated, the Center was reorganized to conduct life science research on ionizing radiation, focusing on carbon ion radiotherapy. This would eventually contribute to the improvement of the quality of life of human beings. Research plans for the fiscal year of 2006 include : clinical study on carbon ion radiotherapy for locally advanced tumors ; development and improvement of radiotherapeutic techniques ; design study and R&D for a new extension of the treatment rooms for the HIMAC ; research on diagnostic imaging ; QA/QC for radiotherapy and radiation protection ; radiobiological experiments for improvement of radiotherapy ; exploration of variability of radiation sensitivity by investigating the SNIPs ; research on HiCEP. The Center is organized of 6 research groups for two major topics (A, B and C). Progress of research for each topic is summarized. a total of 3,178 patients were enrolled in nearly 50 different phase I/II and phase II trials and also in Highly Advanced Medical Technology of carbon ion radiotherapy. In the year 2006, a total of 549 patients with a variety of malignant tumors were treated with carbon ions, in which nearly 75 % of the patients were treated in Highly Advanced Medical Technology.The hypofractionated radiotherapy with employment of larger doses per fraction and shorter overall treatment time as compared to proton or conventional photon radiotherapy has been effectively performed. The average number of fractions per patient was 13 given in 3 weeks. The new MLC having fine leaves has been developed since 2005 and in 2006 the amount of radiation leakage through this MLC was measured. It was found that the ratio of the leakage dose to the unshielded dose for 400 MeV/u carbon beams was measured to be about …

Experimental Verification of Therapeutic Doses for the Superficially-Placed Tumor Radiotherapy with Heavy Ions at Hirfl

A pilot study of function-based radiation therapy planning for lung cancer using hyperpolarized xenon-129 ventilation MRI

[The preliminary report of a registration clinical trial of proton and heavy ion irradiation].

Study of the neutron dose equivalent at the HIRFL deep tumor therapy terminal

Neutron Dose measurement in the carbon ion therapy area at HIRFL (IMP) as 12C ions with energies from 165 to 350MeV/u

Study on neutron radiation field of carbon ions therapy

Flourish of Proton and Carbon Ion Radiotherapy in China

Dosimetric verification on HIMM at the Wuwei heavy ion therapy center using anthropomorphic phantoms

[The Basic Structure of Heavy-Ion Tumor Therapy Facility].

A Review of Update Clinical Results of Carbon Ion Radiotherapy

3. Research Center for Charged Particle Therapy A. Research on the Use of Heavy Ion Beams for Cancer Radiotherapy. ‡@ Development of Advanced Cancer Radio- Therapy with Charged Particle

Research on photogrammetry-based positioning of heavy ion radiotherapy and tumor target monitoring

Verification of linear energy transfer optimized carbon-ion radiotherapy

Experimental Verification of HW-Plan Treatment Planing System

An analysis of the on-going clinical trials on proton and heavy-ion radiation therapy and their impact on the clinical application and future development

Dose Escalated Carbon Ion Radiotherapy for Localized Prostate Cancer in Shanghai Proton and Heavy Ion Center: Toxicity and Efficacy Outcomes At Two Years.

Helical Irradiation of the Total Skin with Dose Painting to Replace Total Skin Electron Beam Therapy for Therapy-Refractory Cutaneous CD4+ T-Cell Lymphoma

Clinical research progress of carbon ion radiotherapy for cancer

Physics and biomedical challenges of cancer therapy with accelerated heavy ions

Three-dimensional conformal and intensity modulated radiation therapy for hepatocellular carcinoma:basic study and clinical trials

Feasibility Study of Three - Dimensional Dose Verification for Intensity Modulated Radiation Therapy Using Gel Dosimeter